AngioDynamics ANGO EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from AngioDynamics’s reported figures.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AngioDynamics's EBIT?
- AngioDynamics (ANGO) reported EBIT of -$12.95M in Q4 2025.
- How has AngioDynamics's EBIT changed year-over-year?
- AngioDynamics's EBIT decreased by 29.8% year-over-year, from -$9.97M to -$12.95M.
- What is the long-term trend for AngioDynamics's EBIT?
- Over 4 years (2021 to 2025), AngioDynamics's EBIT has grown at a 3.2% compound annual growth rate (CAGR), from -$35.28M to -$39.95M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.